1
/
of
1
Typbar (Salmonella Typhi Purified Vi-Capsular Polysaccharide)
Typbar (Salmonella Typhi Purified Vi-Capsular Polysaccharide)
Regular price
₱1,200.00 PHP
Regular price
Sale price
₱1,200.00 PHP
Taxes included.
Quantity
Couldn't load pickup availability
Typbar is an inactivated typhoid vaccine containing Salmonella Typhi purified Vi-capsular polysaccharide, designed to prevent typhoid fever caused by Salmonella enterica serotype Typhi. This injectable vaccine is suitable for individuals aged 2 years and older and is particularly essential for travelers visiting endemic regions, laboratory personnel handling Salmonella typhi, and close contacts of typhoid carriers.
The vaccine offers robust protection when administered at least 2 weeks before travel to typhoid-prone areas. A booster dose is recommended every 2 years to maintain immunity. Typbar works by stimulating the body's immune system to produce antibodies against the Vi-polysaccharide antigen on the bacterial surface, reducing the risk of infection during exposure.
Typhoid remains a significant public health concern in parts of Asia, Africa, and Latin America, where contaminated food and water pose transmission risks. While routine vaccination is not standard in developed countries like the United States, it is strongly recommended for individuals planning travel to or working in regions where typhoid prevalence is high.
This vaccine should be stored refrigerated at 2–8°C and must not be frozen. Administration by a qualified healthcare professional ensures proper dosing and technique. Combined with safe food and water practices during travel, Typbar provides comprehensive protection against this potentially life-threatening bacterial infection.
Consult your healthcare provider to determine if typhoid vaccination is appropriate for your travel plans or occupational exposure risk.
The vaccine offers robust protection when administered at least 2 weeks before travel to typhoid-prone areas. A booster dose is recommended every 2 years to maintain immunity. Typbar works by stimulating the body's immune system to produce antibodies against the Vi-polysaccharide antigen on the bacterial surface, reducing the risk of infection during exposure.
Typhoid remains a significant public health concern in parts of Asia, Africa, and Latin America, where contaminated food and water pose transmission risks. While routine vaccination is not standard in developed countries like the United States, it is strongly recommended for individuals planning travel to or working in regions where typhoid prevalence is high.
This vaccine should be stored refrigerated at 2–8°C and must not be frozen. Administration by a qualified healthcare professional ensures proper dosing and technique. Combined with safe food and water practices during travel, Typbar provides comprehensive protection against this potentially life-threatening bacterial infection.
Consult your healthcare provider to determine if typhoid vaccination is appropriate for your travel plans or occupational exposure risk.
Share
